Loading companies…
Loading companies…
France · Biotech · AI
Develops small-molecule therapies for targeted protein degradation at the point of synthesis
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | €20.7M | Argobio Studio — Role not disclosedBpifrance — Role not disclosedElaia — Role not disclosedInvestSud — Role not disclosedMACSF — Role not disclosedMission BioCapital — Role not disclosedPfizer Ventures — Role not disclosedSambrinvest — Role not disclosedThe Institut Pasteur — Role not disclosedWallonie Entreprendre — Role not disclosed |